A Short Enantioselective Synthesis of Protected l-3-Hydroxy-4-methoxy-5-methyl Phenylalanine and its Corresponding Aldehyde - A Common Subunit of Ecteinascidin-743, Safracin and Congeners

Abstract

An asymmetric synthesis of appropriately protected l-3-hydroxy-4-methoxy-5-methyl phenylalanine from 3-methyl-catechol is described featuring a key enantioselective alkylation step.

amino acid - Ecteinascidin 743 - phase transfer catalyst - glycine template - l-DOPA derivative.

References

1a Rinehart KL. Holt TG. Fregeau NL. Stroh JG. Shield LS. Seigler DS. J. Nat. Prod.  1990,  53:  771 

1b Wright AE. Forleo DA. Gunawardana GP. Gunasekera SP. Koehn FE. McConnell OJ. J. Org. Chem.  1990,  55:  4508 

1c Suwanborirux K. Charupant K. Amnuoypol S. Pummangura S. Kubo A. Saito N. J. Nat. Prod.  2002,  65:  935 

2a Ikeda Y. Shimada Y. Honjo K. Okumoto T. Munakata T. J. Antibiot.  1983,  36:  1290 

2b Saito N. Harada S. Yamashita M. Saito T. Yamaguchi Y. Kubo A. Tetrahedron  1995,  51:  8213 

3 For a recent review, see: Scott JD. Williams RM. Chem. Rev.  2002,  102:  1669 

4a Corey EJ. Gin DY. Kania RS. J. Am. Chem. Soc.  1996,  118:  9202 

4b Corey EJ. Gin DY. Tetrahedron Lett.  1996,  37:  7163 

5a Endo A. Yanagisawa A. Abe M. Tohma S. Kan T. Fukuyama T. J. Am. Chem. Soc.  2002,  124:  2545 

5b Endo A. Kann T. Fukuyama T. Synlett  1999,  7:  1103 

6 Cuevas C. Pérez M. Martin MJ. Chicharro JL. Fernandez-Rivas C. Flores M. Francesch A. Gallego P. Zarzuelo M. De La Calle F. Garcia J. Polanco C. Rodriguez I. Manzanares I. Org. Lett.  2000,  2:  2545 

7a Saito N. Kamayachi H. Tachi M. Kubo A. Heterocycles  1999,  51:  9 

7b Saito N. Tachi M. Seki R. Kamayachi H. Kubo A. Chem. Pharm. Bull.  2000,  48:  1549 

8a Zhou B. Edmondson S. Padron J. Danishefsky SJ. Tetrahedron Lett.  2000,  41:  2039 

8b Zhou B. Guo J. Danishefsky SJ. Tetrahedron Lett.  2000,  41:  2043 

8c Zhou B. Guo J. Danishefsky SJ. Org. Lett.  2002,  4:  43 

9a Jin W. Williams RM. Tetrahedron Lett.  2003,  44:  4635 

9b Jin W. Metobo S. Williams RM. Org. Lett.  2003,  5:  2095 

10 De Paolis M. Chiaroni A. Zhu J. Chem. Commun.  2003,  2896 

11 Corey EJ. Xu F. Noe MC. J. Am. Chem. Soc.  1997,  119:  12414 

12 Lygo B. Wainwright PG. Tetrahedron Lett.  1997,  38:  8595 

13 For an earlier contribution, see: O’Donnell MJ. Bennett WD. J. Am. Chem. Soc.  1989,  111:  2353 

14 Sinhababu AK. Gosh AK. Borchardt RT. J. Med. Chem.  1985,  28:  1273 

15

Compound 6. [α]_D ²³ +13 (c = 0.8, CHCl₃). IR (CHCl₃): 3382, 3034, 2981, 2938, 1725, 1598, 1495, 1370, 1293, 1218, 1178 cm^-1. ¹H NMR (250 MHz, CDCl₃, 293 K): δ = 7.76 (d, J = 7.6 Hz, 2 H), 7.32 (d, J = 7.5 Hz, 2 H), 6.90 (br s, 1 H), 6.79 (br s, 1 H), 3.67 (s, 3 H), 3.48 (dd, J = 7.3, 5.5 Hz, 1 H), 2.88 (dd, J = 13.7, 5.5 Hz, 1 H), 2.67 (dd, J = 13.7, 7.3 Hz, 1 H), 2.44 (s, 3 H), 2.19 (s, 3 H), 1.42 (s, 9 H). ¹³C NMR (75 MHz, CDCl₃, 293 K): 174.0, 149.3, 145.1, 142.2, 133.1, 132.8, 130.4, 129.5, 129.2, 128.5, 128.4, 121.8, 81.2, 60.5, 56.0, 40.2, 28.1, 27.9, 21.6, 15.9. MS (ESI⁺): m/z = 436.2 [M + H]⁺, 458.3 [M + Na]⁺, 474.2 [M + K]⁺. HRMS (ESI⁺): m/z [M + H⁺] calcd for C₂₂H₃₀O₆S: 436.1794; found: 436.1789.
Compound 7. [α]_D ²³ +22 (c = 1, CHCl₃). IR (CHCl₃): 3426, 3024, 2933, 2830, 1716, 1590, 1496, 1343, 1232, 1087, 1007 cm^-1. ¹H NMR (300 MHz, CDCl₃, 293 K): 9.52 (s, 1 H), 6.56 (m, 2 H), 5.96 (ddd, J = 17.7, 12.5, 7.2 Hz, 1 H), 5.82 (m, 1 H), 5.33 (ddt, J = 16.8, 1.7, 1.6 Hz, 1 H), 5.17 (m, 4 H), 4.47 (m, 4 H), 4.46 (m, 1 H), 3.80 (s, 3 H), 2.98 (dd, J = 14.0, 6.5 Hz, 1 H), 2.89 (dd, J = 14.0, 6.8 Hz, 1 H), 2.21 (s, 3 H). ¹³C NMR (75 MHz, CDCl₃, 293 K): 199.2, 155.8, 151.6, 146.7, 133.2, 132.5, 132.3, 130.6, 123.8, 118.0, 117.5, 112.7, 69.4, 65.9, 60.9, 60.1, 35.2, 15.9. MS (ESI⁺): m/z = 334.2 [M + H]⁺.

16a Trost BM. Bunt RC. Pulley SR. J. Org. Chem.  1994,  59:  4202 

16b Helmchen G. Sauber K. Tetrahedron Lett.  1972,  3873